(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Vote In favor of Your Favored Keeping an eye on - 2They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 3Inside Kathy Hilton’s Christmas pajama party: caviar bumps, champagne vending machines and a mansion full of Housewives
- 4Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
- 5Top Pastry: What's Your Sweet Treat of Decision?
- Japan deploys the military to counter a surge in bear attacks
- VPN Administrations for Online Protection
- Manageable Living: Eco-Accommodating Decisions for Regular day to day existence
- Shah Capital pushes for Novavax sale, warns of proxy fight
- Vote in favor of your Favored kind of footwear
- The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- Vote In favor of Your Favored Kind Of Tea
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- The Main 15 Applications for Efficiency and Association
